Global Zika Virus Therapeutic Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR062506944

Publication Date:

June 24, 2025

Pages:

116

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Zika Virus Therapeutic market size was valued at US$ 849 million in 2024 and is forecast to a readjusted size of USD 1267 million by 2031 with a CAGR of 6.0% during review period.
Zika virus infection is triggered by an Aedes mosquito-borne virus that bites during the day. In general, the symptoms include fever, rash, conjunctivitis, muscle and joint pain, malaise, or headache.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Zika Virus Therapeutic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Zika Virus Therapeutic market size and forecasts, in consumption value ($ Million), 2020-2031
Global Zika Virus Therapeutic market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Zika Virus Therapeutic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Zika Virus Therapeutic market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Zika Virus Therapeutic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Zika Virus Therapeutic market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson and Johnson, Aurobindo Pharma, Granules India, Perrigo, Sun Pharmaceutical, Bharat Biotech, Emergent BioSolutions, Takeda Pharmaceutical, GeoVax Labs, IMV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Zika Virus Therapeutic market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Acetaminophen
Other NSAIDs
Market segment by Application
Institutional Pharmacies
Retail Pharmacies
Others
Market segment by players, this report covers
Johnson and Johnson
Aurobindo Pharma
Granules India
Perrigo
Sun Pharmaceutical
Bharat Biotech
Emergent BioSolutions
Takeda Pharmaceutical
GeoVax Labs
IMV
Inovio Pharmaceuticals
Moderna
Merck
Valneva
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Zika Virus Therapeutic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Zika Virus Therapeutic, with revenue, gross margin, and global market share of Zika Virus Therapeutic from 2020 to 2025.
Chapter 3, the Zika Virus Therapeutic competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Zika Virus Therapeutic market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Zika Virus Therapeutic.
Chapter 13, to describe Zika Virus Therapeutic research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Zika Virus Therapeutic by Type
1.3.1 Overview: Global Zika Virus Therapeutic Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Zika Virus Therapeutic Consumption Value Market Share by Type in 2024
1.3.3 Acetaminophen
1.3.4 Other NSAIDs
1.4 Global Zika Virus Therapeutic Market by Application
1.4.1 Overview: Global Zika Virus Therapeutic Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Institutional Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Others
1.5 Global Zika Virus Therapeutic Market Size & Forecast
1.6 Global Zika Virus Therapeutic Market Size and Forecast by Region
1.6.1 Global Zika Virus Therapeutic Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Zika Virus Therapeutic Market Size by Region, (2020-2031)
1.6.3 North America Zika Virus Therapeutic Market Size and Prospect (2020-2031)
1.6.4 Europe Zika Virus Therapeutic Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Zika Virus Therapeutic Market Size and Prospect (2020-2031)
1.6.6 South America Zika Virus Therapeutic Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Zika Virus Therapeutic Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Johnson and Johnson
2.1.1 Johnson and Johnson Details
2.1.2 Johnson and Johnson Major Business
2.1.3 Johnson and Johnson Zika Virus Therapeutic Product and Solutions
2.1.4 Johnson and Johnson Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Johnson and Johnson Recent Developments and Future Plans
2.2 Aurobindo Pharma
2.2.1 Aurobindo Pharma Details
2.2.2 Aurobindo Pharma Major Business
2.2.3 Aurobindo Pharma Zika Virus Therapeutic Product and Solutions
2.2.4 Aurobindo Pharma Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Aurobindo Pharma Recent Developments and Future Plans
2.3 Granules India
2.3.1 Granules India Details
2.3.2 Granules India Major Business
2.3.3 Granules India Zika Virus Therapeutic Product and Solutions
2.3.4 Granules India Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Granules India Recent Developments and Future Plans
2.4 Perrigo
2.4.1 Perrigo Details
2.4.2 Perrigo Major Business
2.4.3 Perrigo Zika Virus Therapeutic Product and Solutions
2.4.4 Perrigo Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Perrigo Recent Developments and Future Plans
2.5 Sun Pharmaceutical
2.5.1 Sun Pharmaceutical Details
2.5.2 Sun Pharmaceutical Major Business
2.5.3 Sun Pharmaceutical Zika Virus Therapeutic Product and Solutions
2.5.4 Sun Pharmaceutical Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Sun Pharmaceutical Recent Developments and Future Plans
2.6 Bharat Biotech
2.6.1 Bharat Biotech Details
2.6.2 Bharat Biotech Major Business
2.6.3 Bharat Biotech Zika Virus Therapeutic Product and Solutions
2.6.4 Bharat Biotech Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bharat Biotech Recent Developments and Future Plans
2.7 Emergent BioSolutions
2.7.1 Emergent BioSolutions Details
2.7.2 Emergent BioSolutions Major Business
2.7.3 Emergent BioSolutions Zika Virus Therapeutic Product and Solutions
2.7.4 Emergent BioSolutions Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Emergent BioSolutions Recent Developments and Future Plans
2.8 Takeda Pharmaceutical
2.8.1 Takeda Pharmaceutical Details
2.8.2 Takeda Pharmaceutical Major Business
2.8.3 Takeda Pharmaceutical Zika Virus Therapeutic Product and Solutions
2.8.4 Takeda Pharmaceutical Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Takeda Pharmaceutical Recent Developments and Future Plans
2.9 GeoVax Labs
2.9.1 GeoVax Labs Details
2.9.2 GeoVax Labs Major Business
2.9.3 GeoVax Labs Zika Virus Therapeutic Product and Solutions
2.9.4 GeoVax Labs Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 GeoVax Labs Recent Developments and Future Plans
2.10 IMV
2.10.1 IMV Details
2.10.2 IMV Major Business
2.10.3 IMV Zika Virus Therapeutic Product and Solutions
2.10.4 IMV Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 IMV Recent Developments and Future Plans
2.11 Inovio Pharmaceuticals
2.11.1 Inovio Pharmaceuticals Details
2.11.2 Inovio Pharmaceuticals Major Business
2.11.3 Inovio Pharmaceuticals Zika Virus Therapeutic Product and Solutions
2.11.4 Inovio Pharmaceuticals Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Inovio Pharmaceuticals Recent Developments and Future Plans
2.12 Moderna
2.12.1 Moderna Details
2.12.2 Moderna Major Business
2.12.3 Moderna Zika Virus Therapeutic Product and Solutions
2.12.4 Moderna Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Moderna Recent Developments and Future Plans
2.13 Merck
2.13.1 Merck Details
2.13.2 Merck Major Business
2.13.3 Merck Zika Virus Therapeutic Product and Solutions
2.13.4 Merck Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Merck Recent Developments and Future Plans
2.14 Valneva
2.14.1 Valneva Details
2.14.2 Valneva Major Business
2.14.3 Valneva Zika Virus Therapeutic Product and Solutions
2.14.4 Valneva Zika Virus Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Valneva Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Zika Virus Therapeutic Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Zika Virus Therapeutic by Company Revenue
3.2.2 Top 3 Zika Virus Therapeutic Players Market Share in 2024
3.2.3 Top 6 Zika Virus Therapeutic Players Market Share in 2024
3.3 Zika Virus Therapeutic Market: Overall Company Footprint Analysis
3.3.1 Zika Virus Therapeutic Market: Region Footprint
3.3.2 Zika Virus Therapeutic Market: Company Product Type Footprint
3.3.3 Zika Virus Therapeutic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Zika Virus Therapeutic Consumption Value and Market Share by Type (2020-2025)
4.2 Global Zika Virus Therapeutic Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Zika Virus Therapeutic Consumption Value Market Share by Application (2020-2025)
5.2 Global Zika Virus Therapeutic Market Forecast by Application (2026-2031)
6 North America
6.1 North America Zika Virus Therapeutic Consumption Value by Type (2020-2031)
6.2 North America Zika Virus Therapeutic Market Size by Application (2020-2031)
6.3 North America Zika Virus Therapeutic Market Size by Country
6.3.1 North America Zika Virus Therapeutic Consumption Value by Country (2020-2031)
6.3.2 United States Zika Virus Therapeutic Market Size and Forecast (2020-2031)
6.3.3 Canada Zika Virus Therapeutic Market Size and Forecast (2020-2031)
6.3.4 Mexico Zika Virus Therapeutic Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Zika Virus Therapeutic Consumption Value by Type (2020-2031)
7.2 Europe Zika Virus Therapeutic Consumption Value by Application (2020-2031)
7.3 Europe Zika Virus Therapeutic Market Size by Country
7.3.1 Europe Zika Virus Therapeutic Consumption Value by Country (2020-2031)
7.3.2 Germany Zika Virus Therapeutic Market Size and Forecast (2020-2031)
7.3.3 France Zika Virus Therapeutic Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Zika Virus Therapeutic Market Size and Forecast (2020-2031)
7.3.5 Russia Zika Virus Therapeutic Market Size and Forecast (2020-2031)
7.3.6 Italy Zika Virus Therapeutic Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Zika Virus Therapeutic Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Zika Virus Therapeutic Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Zika Virus Therapeutic Market Size by Region
8.3.1 Asia-Pacific Zika Virus Therapeutic Consumption Value by Region (2020-2031)
8.3.2 China Zika Virus Therapeutic Market Size and Forecast (2020-2031)
8.3.3 Japan Zika Virus Therapeutic Market Size and Forecast (2020-2031)
8.3.4 South Korea Zika Virus Therapeutic Market Size and Forecast (2020-2031)
8.3.5 India Zika Virus Therapeutic Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Zika Virus Therapeutic Market Size and Forecast (2020-2031)
8.3.7 Australia Zika Virus Therapeutic Market Size and Forecast (2020-2031)
9 South America
9.1 South America Zika Virus Therapeutic Consumption Value by Type (2020-2031)
9.2 South America Zika Virus Therapeutic Consumption Value by Application (2020-2031)
9.3 South America Zika Virus Therapeutic Market Size by Country
9.3.1 South America Zika Virus Therapeutic Consumption Value by Country (2020-2031)
9.3.2 Brazil Zika Virus Therapeutic Market Size and Forecast (2020-2031)
9.3.3 Argentina Zika Virus Therapeutic Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Zika Virus Therapeutic Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Zika Virus Therapeutic Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Zika Virus Therapeutic Market Size by Country
10.3.1 Middle East & Africa Zika Virus Therapeutic Consumption Value by Country (2020-2031)
10.3.2 Turkey Zika Virus Therapeutic Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Zika Virus Therapeutic Market Size and Forecast (2020-2031)
10.3.4 UAE Zika Virus Therapeutic Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Zika Virus Therapeutic Market Drivers
11.2 Zika Virus Therapeutic Market Restraints
11.3 Zika Virus Therapeutic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Zika Virus Therapeutic Industry Chain
12.2 Zika Virus Therapeutic Upstream Analysis
12.3 Zika Virus Therapeutic Midstream Analysis
12.4 Zika Virus Therapeutic Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Johnson and Johnson
Aurobindo Pharma
Granules India
Perrigo
Sun Pharmaceutical
Bharat Biotech
Emergent BioSolutions
Takeda Pharmaceutical
GeoVax Labs
IMV
Inovio Pharmaceuticals
Moderna
Merck
Valneva

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂